Inhibrx Biosciences, Inc.INBXNASDAQ
Loading
Operating Margin Over TimeExpanding
Percentile Rank22
Studio
Year-over-Year Change

Operating income as a percentage of revenue

Latest
-10386.54%
↑ 47% vs avg
Percentile
P22
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-19708.56%
Historical baseline
PeriodValueYoY Change
TTM-10386.54%+93.7%
2024-165724.00%-1260.7%
2023-12178.94%-106.8%
2022-5890.37%-448.2%
2021-1074.58%-104.1%
2020-526.57%-9.5%
2019-480.74%-22.2%
2018-393.51%-58.6%
2017-248.15%-36.2%
2016-182.18%-